Treatment of patients dependent on tobacco with fluphenazine decanoate
Drtil, J.
Activitas Nervosa Superior 31(2): 116-117
1989
ISSN/ISBN: 0001-7604 PMID: 2800941 Document Number: 338719
Document emailed within 1 workday
Related Documents
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824Stevens, B. 1976: The social value of fluphenazine decanoate Acta Psychiatrica Belgica 76(5): 792-804
Small, J.G.; Kellams, J. 1974: Early hospital experience with fluphenazine decanoate Diseases of the Nervous System 35(10): 453-456
Náhunek, K.; Rodová, A.; Svestka, J. 1970: Clinical experience with fluphenazine decanoate in psychoses Activitas Nervosa Superior 12(1): 47-49
Timm, U.; Pfeifer, S. 1973: Assay and determination of fluphenazine decanoate in oily solution Die Pharmazie 28(11): 793
Grosser, H.H. 1970: Experience of psychiatric management of schizophrenia with fluphenazine decanoate Diseases of the Nervous System 31(Suppl): 32-36
Adamson, L.; Curry, S.H.; Bridges, P.K.; Firestone, A.F.; Lavin, N.I.; Lewis, D.M.; Watson, R.D.; Xavier, C.M.; Anderson, J.A. 1973: Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine Diseases of the Nervous System 34(4): 181-191
Jain, R.C.; Ananth, J.V.; Lehmann, H.E.; Ban, T.A. 1975: A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients Current Therapeutic Research 18(4): 585-589
Walker, C.A. 1983: A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients Pharmatherapeutica 3(5): 289-293
Wintrob, R.M. 1970: Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment Diseases of the Nervous System 31(Suppl): 50-62
Lagomarsino, A.J. 1987: Haloperidol decanoate in psychotic patients Acta Psiquiatrica y Psicologica de America Latina 33(3): 181
Zbytovský, J. 1993: Haloperidol decanoate (Janssen) in the treatment of schizophrenia Ceskoslovenska Psychiatrie 89(1): 27-29
Kabes, J.; Balon, R.; Papezová, H. 1986: Maintenance therapy using clopenthixol decanoate in schizophrenic patients Ceskoslovenska Psychiatrie 82(3-4): 189-194
Leksowski, W. 1983: Status epilepticus as a complication of fluphenazine treatment Psychiatria Polska 17(5-6): 445-447
Connolly, R.G. 1981: Treatment of fibromyositis with fluphenazine and amitriptyline: a preliminary report Delaware Medical Journal 53(4): 189-191
Niturad, A.; Ciurezu, T.; Cucu, I. 1974: Maintenance treatment of schizophrenia with long-acting fluphenazine Activitas Nervosa Superior 16(3): 167
Ellerman, L.A. 1987: Open clinical trial with haloperidol decanoate in patients with psychotic disorders Acta Psiquiatrica y Psicologica de America Latina 33(2): 157-162
Roncoroni, D. 1984: Long-term therapy of chronic schizophrenic patients with haloperidol decanoate Psychiatrische Praxis 11(2): 56-58
Castellani, S. 1985: Catatonia associated with phenylpropanolamine overdose and fluphenazine treatment: case report Journal of Clinical Psychiatry 46(7): 288-289
Mora, C.; Macía, M.L.; García, J.; Navarro, J.F. 2001: Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 611-614